Award
Delivery Order #SPE2DR26FA2EA
Delivery Order for Lidocaine Hydrochloride under Pharmaceutical Distribution Contract
Buyer
Defense Logistics Agency
Award Amount
$113.77
Ceiling
$113.77
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 09, 2026
Identifier
SPE2DR26FA2EA
NAICS
424210
This award represents a delivery order contract under a previously established indefinite delivery vehicle for pharmaceutical distribution. The recipient, AmerisourceBergen Drug Corp, is a leading global pharmaceutical sourcing and distribution company recognized for efficiently supplying medications and healthcare products. The specific product procured in this instance is Lidocaine Hydrochloride 2% administered in 5 ML doses, a vital local anesthetic used in various medical treatments. This delivery order ensures the timely provision of this essential pharmaceutical within a short operational timeframe, emphasizing the agency's commitment to maintaining adequate medical supplies. The contract falls under the broader pharmaceutical distribution program, supporting healthcare facilities' continuous needs. The award was competitively aligned with the existing contract framework, leveraging AmerisourceBergen's established capability and proven performance. The delivery takes place in Conshohocken, Pennsylvania, scheduled for a concise period in early March 2026, reflecting a prompt fulfillment of agency pharmaceutical requirements.
Description
4571062847!LIDOCAINE HCL 2% 100 MG/5 ML 5ML